CTGF
CTGF (cellular communication network factor 2, encoded by CCN2, also known as IGFBP8) is a secreted member of the CCN family. It acts as a connective tissue mitoattractant and mitogen released by vascular endothelial cells, and it influences cell adhesion, chondrocyte growth and bone formation. Browse Assay Genie's current range of CTGF research reagents below, or read on for the biology behind the target.
CTGF is described in UniProt as a major connective tissue mitoattractant secreted by vascular endothelial cells. It promotes the proliferation and differentiation of chondrocytes, stimulates osteoblast differentiation and has a critical role in osteogenesis. It also mediates heparin- and divalent cation-dependent cell adhesion in many cell types, including fibroblasts, myofibroblasts, endothelial cells and epithelial cells, and it enhances fibroblast growth factor-induced DNA synthesis.
The CTGF protein is secreted into the extracellular space, where it is found in the extracellular matrix. It belongs to the CCN family, which HGNC groups as the cellular communication network factors. The CTGF gene carries the approved symbol CCN2, and the mouse and rat orthologues are both named Ccn2. Related CCN family members include CCN1, CCN3 and CCN4.
The protein was originally named connective tissue growth factor, which gives the CTGF abbreviation, and it is also listed under the alias IGFBP8. NCBI Gene notes that the protein is related to platelet-derived growth factor and plays a role in chondrocyte proliferation and differentiation and in cell adhesion. Certain polymorphisms in the gene have been linked with a higher incidence of systemic sclerosis, which makes CTGF a point of interest in connective tissue and fibrotic disease research.
CTGF mediates adhesion of fibroblasts and myofibroblasts and enhances fibroblast growth factor-induced DNA synthesis, so it is relevant to studies of connective tissue cells.
CTGF promotes chondrocyte proliferation and differentiation and stimulates osteoblast differentiation, with a critical role in osteogenesis.
CTGF is a mitoattractant secreted by vascular endothelial cells and mediates adhesion of endothelial cells, linking it to vascular and matrix research.
Certain polymorphisms in the CCN2 gene have been linked with a higher incidence of systemic sclerosis, supporting its use in connective tissue disease studies.
CTGF is a secreted mitogen and connective tissue mitoattractant. It promotes chondrocyte proliferation and differentiation, stimulates osteoblast differentiation, mediates heparin- and divalent cation-dependent cell adhesion, and enhances fibroblast growth factor-induced DNA synthesis.
CTGF stands for connective tissue growth factor, the original name. HGNC now uses CCN2, cellular communication network factor 2, reflecting its place in the CCN family. IGFBP8 is a further listed alias. Literature and product listings may use any of these names.
Mouse and rat both have a Ccn2 orthologue. NCBI Gene reports that certain polymorphisms in the human gene are linked with a higher incidence of systemic sclerosis. Check the datasheet of any product for its validated reactivity.
Other CCN family members that share the matricellular, secreted character of CTGF.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P29279; product specifications from Assay Genie datasheets.